MedPath
TGA Approval

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender (206764)

206764

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender

Bristol-Myers Squibb Australia Pty Ltd

May 30, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/fa39a9328c2386ba0f85868924ffb045.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/53dede8ca34c80c29fe90c422fcf2d8b.pdf

Active Ingredients

Abatacept

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender (206764) - TGA 批准文号 | MedPath